![](/img/cover-not-exists.png)
A Randomized, Double-blind, Placebo-controlled Phase 2 Study of Ontuxizumab (MORAb-004) in Patients with Chemorefractory Metastatic Colorectal Cancer
Grothey, Axel, Strosberg, Jonathan R, Renfro, Lindsay A, Hurwitz, Herbert I., Marshall, John, Safran, Howard, Guarino, Michael J, Kim, George P., Hecht, J. Randolph, Weil, Susan C., Heyburn, John, WanLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-17-1558
Date:
October, 2017
File:
PDF, 1.20 MB
english, 2017